Please assess the completion status of the following clinical trial:

Trial Title: Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Received engineered cellular immunotherapy in a Fate Therapeutics Interventional Study~Exclusion Criteria:~• Not Applicable

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Genetically engineered NK Cell - treated (Type: None): Long term follow-up of subjects who have received lentivirus-mediated genetically engineered NK Cells.

Based on this trial design, predict the completion outcome and termination type (if applicable).